ClinicalTrials.Veeva

Menu

Predictability of the Pulse Pressure Variation (PPV) During Spontaneous Ventilation on the Incidence of Hypotension During Induction of Anesthesia

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Hypotension

Treatments

Drug: Volume loading
Other: PPV<14%
Other: PPV>14%

Study type

Interventional

Funder types

Other

Identifiers

NCT02208570
JHBahk_PPV_predictability

Details and patient eligibility

About

The purpose of this study is to find out the predictability of the pulse pressure variation during spontaneous ventilation on the incidence of hypotension during induction of anesthesia.

Enrollment

172 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing general anesthesia induction with intravenous anesthesia using propofol and remifentanil
  • Patients requiring invasive arterial blood pressure monitoring for the surgery

Exclusion criteria

  • Refusal of consent
  • Patients with heart disease (symptomatic valvular heart disease, intracardiac shunt, pulmonary hypertension with pulmonary systolic arterial pressure exceeding 40mmHg)
  • FEV1 ≤ 50% predicted FEV1
  • Patients with chronic renal failure
  • ASA class IV, V, VI
  • Systolic arterial blood pressure below 90mmHg before induction of anesthesia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

172 participants in 4 patient groups

P(+)V(+)
Experimental group
Description:
PPV\>14% before anesthesia induction, HES 6ml/kg infused
Treatment:
Other: PPV>14%
Drug: Volume loading
P(+)V(-)
Experimental group
Description:
PPV\>14% before anesthesia induction, no additional volume infused
Treatment:
Other: PPV>14%
P(-)V(+)
Experimental group
Description:
PPV\<14% before anesthesia induction, HES 6ml/kg infused
Treatment:
Drug: Volume loading
Other: PPV<14%
P(-)V(-)
Experimental group
Description:
PPV\<14% before anesthesia induction, no additional volume infused
Treatment:
Other: PPV<14%

Trial contacts and locations

1

Loading...

Central trial contact

Jae-Hyon Bahk

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems